Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Chronic Pain × Morphine × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Pain 4 Cancer Pain 4 Substance Withdrawal Syndrome 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Chronic Pain 1

Interventions

Fentanyl 2 ziconotide 1 nabiximols 1 morphine, naltrexone combination 1 Tapentadol 1 Naltrexone 1 Morphine 1 Ketamine 1 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Pfizer

Phase 4 Terminated

14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡